Rapid detection of epidermal growth factor receptor mutations with multiplex PCR and primer extension in lung cancer

被引:10
作者
Lin, Ching-Hsiung [2 ]
Yeh, Kun-Tu [3 ]
Chang, Ya-Sian [1 ,4 ]
Hsu, Nicholas C. [1 ]
Chang, Jan-Gowth [1 ,5 ,6 ]
机构
[1] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan
[2] Changhua Christian Hosp, Dept Chest Med, Changhua, Taiwan
[3] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan
[4] Natl Chung Hsiung Univ, Dept Vet Med, Taichung, Taiwan
[5] Kaohsiung Med Univ, Inst Clin Med, Kaohsiung, Taiwan
[6] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan
关键词
EGFR MUTATIONS; GENE-MUTATIONS; GEFITINIB; SENSITIVITY; PREDICTORS; EXPRESSION; SURVIVAL; COMMON; IMPACT;
D O I
10.1186/1423-0127-17-37
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Epidermal growth factor receptor (EGFR) kinase domain mutations hyperactivate the kinase and confer kinase addiction of the non-small-cell lung cancer (NSCLC) tumor cells. Almost all of these mutations are located within exons 18-21. The -216 single nucleotide polymorphism in the promoter region is associated with increased EGFR production. We present a method for detecting these common mutations in 81 cases of NSCLC. The protocol is based on the multiplex amplification of promoter region and exons 18-21 of the EGFR genes in a single tube, followed by primer extension of the PCR products using various sizes of primers to detect base changes at -216 promoter region and codons 719, 746-750, 790, 858 of the EGFR gene. We compared the results with that from direct sequencing for detecting EGFR mutations in 81 cases of NSCLC. The two methods identified the same 26 mutations, but our method is superior to direct sequencing in terms of the amount of work and time required. We presented a simple and fast method to detect mutations of EGFR genes in NSCLC.
引用
收藏
页数:6
相关论文
共 28 条
[1]   The new World Health Organization classification of lung tumours [J].
Brambilla, E ;
Travis, WD ;
Colby, TV ;
Corrin, B ;
Shimosato, Y .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (06) :1059-1068
[2]   Epidermal growth factor receptor inhibitors and their role in non-small-cell lung cancer [J].
Byrne B.J. ;
Garst J. .
Current Oncology Reports, 2005, 7 (4) :241-247
[3]   Fast simultaneous detection of K-RAS mutations in colorectal cancer [J].
Chang, Ya-Sian ;
Yeh, Kun-Tu ;
Chang, Tien-Jye ;
Chai, Connie ;
Lu, Hsiu-Chin ;
Hsu, Nicholas C. ;
Chang, Jan-Gowth .
BMC CANCER, 2009, 9
[4]   Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib [J].
Han, SW ;
Kim, TY ;
Hwang, PG ;
Jeong, S ;
Kim, J ;
Choi, IS ;
Oh, DY ;
Kim, LH ;
Kim, DW ;
Chung, DH ;
Im, SA ;
Kim, YT ;
Lee, JS ;
Heo, DS ;
Bang, YJ ;
Kim, NK .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (11) :2493-2501
[5]   Epidermal growth factor receptor in non-small-cell lung carcinomas:: Correlation between gene copy number and protein expression and impact on prognosis [J].
Hirsch, FR ;
Varella-Garcia, M ;
Bunn, PA ;
Di Maria, MV ;
Veve, R ;
Bremnes, RM ;
Barón, AE ;
Zeng, C ;
Franklin, WA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) :3798-3807
[6]   Presence of epidermal growth factor receptor gene T790M mutation as a minor clone in non-small cell lung cancer [J].
Inukai, Michio ;
Toyooka, Shinichi ;
Ito, Sachio ;
Asano, Hiroaki ;
Ichihara, Shuji ;
Soh, Junichi ;
Suehisa, Hiroshi ;
Ouchida, Mamoru ;
Aoe, Keisuke ;
Aoe, Motoi ;
Kiura, Katsuyuki ;
Shimizu, Nobuyoshi ;
Date, Hiroshi .
CANCER RESEARCH, 2006, 66 (16) :7854-7858
[7]   Epidermal growth factor receptor mutations in non-small-cell lung cancer:: Implications for treatment and tumor biology [J].
Jänne, PA ;
Engelman, JA ;
Johnson, BE .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (14) :3227-3234
[8]   EGFR mutation and resistance of non-small-cell lung cancer to gefitinib [J].
Kobayashi, S ;
Boggon, TJ ;
Dayaram, T ;
Janne, PA ;
Kocher, O ;
Meyerson, M ;
Johnson, BE ;
Eck, MJ ;
Tenen, DG ;
Halmos, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :786-792
[9]   Mutations of the epidermal growth factor receptor gene in lung cancer:: Biological and clinical implications [J].
Kosaka, T ;
Yatabe, Y ;
Endoh, H ;
Kuwano, H ;
Takahashi, T ;
Mitsudomi, T .
CANCER RESEARCH, 2004, 64 (24) :8919-8923
[10]   Tyrosine kinases as targets for cancer therapy [J].
Krause, DS ;
Van Etten, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02) :172-187